phase readout
saveNCT07446855: Study of AZD4956 as Monotherapy and in Combination With Anti-Cancer Agents in Participants With Advanced/Metastatic Homologous Recombination Deficient Solid Tumours
RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Solid Tumours
view source ↗
comments(0)
5-min edit window · permanent after that